Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 4/18/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Kate Bingham Managing Partner

Wrong Dr. Kate Bingham Managing Partner?

Managing Partner

Phone: +44 **********  
Email: k***@***.com
Local Address:  London , London , United Kingdom
SV Life Sciences
1700 Owens St Ste 184
San Francisco , California 94158
United States

Company Description: SV Life Sciences is a venture capital adviser and manager that makes selected investments in entrepreneurs and management teams. SV Life Sciences provides...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • Biochemistry
    Oxford University
  • MBA
    Harvard Business School
  • Masters degree , Biochemistry
    Oxford University
  • first class Masters degree , Biochemistry
    University Oxford
  • first class degree , Biochemistry
    Oxford University
165 Total References
Web References
LifeSci has met with SV Life ...
www.biospace.com [cached]
LifeSci has met with SV Life Sciences Managing Partner Kate Bingham and BioCentury Co-Founder & Chairwoman Karen Bernstein, the co-authors of an open letter that criticized the company’s January event, as well as well-known industry leaders, CEOs, management teams, boards of directors, members of the media, leading diversity advocates in the life sciences field and clients throughout the U.S., Europe and Israel to determine concrete steps for moving forward.
...
The board will be co-chaired by Knightsbridge Advisers Managing Principal Barbara Piette and Stem for Life Foundation Founder Robin Smith, MD MBA, and includes other industry leaders Renee Gala, CFO, Theravance Biopharma, Annalisa Jenkins MBBS MRCP, President and CEO of Dimension Therapeutics, and Kate Bingham, Managing Partner at SV Life Sciences, among others.
LifeSci met with the authors ...
www.biospace.com [cached]
LifeSci met with the authors of the critical letter, Kate Bingham, a managing partner of SV Life Sciences, and “BioCentury� co-founder Karen Bernstein, to discuss its proposed initiatives.
LifeSci met with the authors ...
www.biospace.com [cached]
LifeSci met with the authors of the critical letter, Kate Bingham, a managing partner of SV Life Sciences, and “BioCentury� co-founder Karen Bernstein, to discuss its proposed initiatives.
LifeSci has met with SV Life ...
www.biospace.com [cached]
LifeSci has met with SV Life Sciences Managing Partner Kate Bingham and BioCentury Co-Founder & Chairwoman Karen Bernstein, the co-authors of an open letter that criticized the company’s January event, as well as well-known industry leaders, CEOs, management teams, boards of directors, members of the media, leading diversity advocates in the life sciences field and clients throughout the U.S., Europe and Israel to determine concrete steps for moving forward.
...
The board will be co-chaired by Knightsbridge Advisers Managing Principal Barbara Piette and Stem for Life Foundation Founder Robin Smith, MD MBA, and includes other industry leaders Renee Gala, CFO, Theravance Biopharma, Annalisa Jenkins MBBS MRCP, President and CEO of Dimension Therapeutics, and Kate Bingham, Managing Partner at SV Life Sciences, among others.
The Board | Convergence Pharmaceuticals:
www.calchan.co.uk [cached]
Kate Bingham, Managing Partner - SV Life Sciences
Kate Bingham joined SVLS in 1991. Kate currently serves or has served on the boards of companies in the UK, US, Ireland, Sweden and Germany. She has been responsible for past investments in Alantos, Auxilium, ESBATech, Hexagen, Kinetix, KuDOS, Leukosite, Mednova, Micromet, PowderMed, RespiVert and current investments including Autifony, Bicycle, Convergence, EUSA and TopiVert. Prior to joining SVLS, Kate worked in business development for Vertex Pharmaceuticals, a biotechnology company in Cambridge, MA and at Monitor Company, a strategy consulting firm. Kate has a first class degree in Biochemistry from Oxford University and graduated from Harvard Business School with an MBA.
John Aston OBE
John Aston was Chief Financial Officer of Cambridge Antibody Technology (CAT) between 1996 and 2006.
Other People with the name "Bingham":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.